Glypican-3 | ApexOnco - Clinical Trials news and analysis

x

“OncologyPipeline is my favorite CI tool”

Head of Market Insights Oncology Europe

Daiichi Sankyo

Click here for more information

Deals

2 January 2024

Bristol makes its radiopharma move

The group’s $4.1bn swoop for RayzeBio follows big deals from Novartis and Lilly.

Subscribe to Glypican-3